Cargando…
582. Risk Factors for Progression to Hospitalization in Adolescents Presenting with Mild or Moderate COVID-19
BACKGROUND: Most adolescents (age 12-17 years) with COVID-19 have mild disease. However, certain comorbidities may be risk factors for disease progression, and hospitalization rates for this age group have increased. Adolescents and adults with mild to moderate COVID-19 are eligible for monoclonal a...
Autores principales: | Dubois, Melanie, Campbell, Jeffrey, Lamb, Gabriella S, Nakamura, Mari M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644454/ http://dx.doi.org/10.1093/ofid/ofab466.780 |
Ejemplares similares
-
82. Multisystem Inflammatory Syndrome in Children and non-sars-cov-2 Infections: A Retrospective Cross-sectional Study
por: Campbell, Jeffrey, et al.
Publicado: (2020) -
Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Coronavirus Disease 2019
por: Campbell, Jeffrey I., et al.
Publicado: (2022) -
646. Increasing Use of Interferon-Gamma Release Assay to Test for Pediatric Tuberculosis in a Low-Burden Setting
por: Campbell, Jeffrey, et al.
Publicado: (2021) -
655. Patterns of Interferon-Gamma Release Assay (IGRA) Testing for Tuberculosis in Patients Less Than 2 Years Old
por: Tabatneck, Mary, et al.
Publicado: (2021) -
347. Etiologies in a Cohort of Pediatric Patients Who Underwent CSF Metagenomic Next Generation Sequencing
por: Wilson-Murphy, Molly, et al.
Publicado: (2020)